Bioceltix staff visited Spain for almost a week in order to finalise an equipment order for our laboratory. During these few days, we explored ... More

The Bioceltix team is developing its technology, upgrading its workspace to GMP standards and expanding its team. Our specialists were joined by ... More

Bioceltix has selected a supplier of isolated production line equipment. The contract has been awarded to the Czech company – BLOCK. The tender ... More

What are the differences between pharmaceuticals produced via chemical synthesis and stem cell-based biopharmaceuticals? Why is the efficacy and ... More

Our Research and Development Centre and the cGMP-compliant manufacturing facility are located at EIT+, which is one of the most comprehensive ... More

We wouldn’t dare miss the annual “Gospodarcze Otwarcie Roku” (Business Opening of the Year) conference on 21 February 2018. The meeting allows ... More

What has science yet to discover about the mechanisms of action of MSCs? Is it possible to replace living stem cells without sacrificing the ... More

We are a team is dedicated to the constant search for new biotechnology solutions. We create top-of-the-line stem cell-based pharmaceuticals for ... More

Bioceltix is implementing the project entitled “The production of adipose tissue-derived allogeneic mesenchymal stem cells as compliant with the ... More

Bioceltix is implementing the project entitled “The production of adipose tissue-derived allogeneic mesenchymal stem cells as compliant with the ... More